Otvoreni postupak · Roba
Napomene date u Tenderskoj dokumentaciji.
| Partija | Status | Procijenjeno | Dodijeljeno | Datum ugovora |
|---|---|---|---|---|
| vildagliptin, metformin | Active | 21.447,27 € | — | — |
| raltegravir | Active | 273.561,20 € | — | — |
| sofosbuvir, velpatasvir | Active | 86.224,60 € | — | — |
| glekaprevir, pibrentasvir | Active | 43.295,24 € | — | — |
| trifluridin, tipiracil | Active | 48.195,68 € | — | — |
| trifluridin, tipiracil | Active | 119.687,20 € | — | — |
| nilotinib | Active | 46.557,94 € | — | — |
| izavukonazol | Active | 5.627,50 € | — | — |
| nilotinib | Active | 26.520,70 € | — | — |
| vemurafenib | Active | 29.371,50 € | — | — |
| alektinib | Active | 30.041,27 € | — | — |
| brigatinib | Active | 1.567,16 € | — | — |
| brigatinib | Active | 7.001,79 € | — | — |
| brigatinib | Active | 15.327 € | — | — |
| trametinib | Active | 75.393,99 € | — | — |
| asciminib | Active | 10.985,94 € | — | — |
| ciproteron | Active | 445,97 € | — | — |
| etinilestradiol, levonorgestrel | Active | 261,36 € | — | — |
| valsartan, sakubitril | Active | 33.081,36 € | — | — |
| saksagliptin | Active | 19.221,10 € | — | — |
| empagliflozin | Active | 110.212,76 € | — | — |
| empagliflozin | Active | 117.129,60 € | — | — |
| liraglutid | Active | 535.454,70 € | — | — |
| dapagliflozin | Active | 394.820,50 € | — | — |
| tikagrelor | Active | 13.620,08 € | — | — |
| dabigatraneteksilat | Active | 34.540 € | — | — |
| dabigatraneteksilat | Active | 31.592 € | — | — |
| rivaroksaban | Active | 5.435,10 € | — | — |
| rivaroksaban | Active | 36.417,36 € | — | — |
| rivaroksaban | Active | 70.022,89 € | — | — |
| apiksaban | Active | 89.995,86 € | — | — |
| apiksaban | Active | 103.654,10 € | — | — |
| valsartan, sakubitril | Active | 148.453,55 € | — | — |
| valsartan, sakubitril | Active | 98.954,46 € | — | — |
| kobimetinib | Active | 24.144,95 € | — | — |
| ribociklib | Active | 286.042,75 € | — | — |
| lapatinib | Active | 4.534 € | — | — |
| alpelisib | Active | 31.884,10 € | — | — |
| indakaterol, glikopironijum bromid | Active | 7.244,82 € | — | — |
| formoterol, glikopironijum bromid, beklometazon | Active | 6.189,15 € | — | — |
| timolol, brinzolamid | Active | 14.269,23 € | — | — |
| eltrombopag | Active | 24.922,88 € | — | — |
| eltrombopag | Active | 85.888,17 € | — | — |
| aksitinib | Active | 1.803,24 € | — | — |
| aksitinib | Active | 58.931,40 € | — | — |
| akalabrutinib | Active | 73.914,26 € | — | — |
| ruksolitinib | Active | 73.964,50 € | — | — |
| ruksolitinib | Active | 5.868,50 € | — | — |
| ruksolitinib | Active | 88.027,50 € | — | — |
| ibrutinib | Active | 429.434,98 € | — | — |
| lenalidomid | Active | 106.354,76 € | — | — |
| lenalidomid | Active | 74.525,94 € | — | — |
| risdiplam | Active | 156.548,70 € | — | — |
| budesonid, formoterol | Active | 49.056,93 € | — | — |
| metformin+dapaglifozin | Active | 141.485,40 € | — | — |
| budesonid, formoterol | Active | 7.600,32 € | — | — |
| budesonid, formoterol | Active | 1.832,96 € | — | — |
| sunitinib | Active | 8.896,74 € | — | — |
| pazopanib | Active | 6.932,19 € | — | — |
| dabrafenib | Active | 176.016,60 € | — | — |
| osimertinib | Active | 106.698,11 € | — | — |
| enzalutamid | Active | 62.479,04 € | — | — |
| apalutamid | Active | 478.538,40 € | — | — |
| darolutamid | Active | 40.281,64 € | — | — |
| eksemestan | Active | 2.444,40 € | — | — |
| abirateron | Active | 15.461 € | — | — |
| fingolimod | Active | 23.642,88 € | — | — |
| tofacitinib | Active | 61.696,88 € | — | — |
| teriflunomid | Active | 31.394,79 € | — | — |
| kladribin | Active | 196.322,40 € | — | — |
| upadacitinib | Active | 80.077,40 € | — | — |
| dimetilfumarat | Active | 92.334,08 € | — | — |
| budesonid, formoterol | Active | 31.545,54 € | — | — |
| ikatibant | Active | 100.732,30 € | — | — |
| daratumumab | Active | 331.497,56 € | — | — |
| insulin degludek | Active | 559.110,30 € | — | — |
| lanreotid | Active | 32.534,55 € | — | — |
| izavukonazol | Active | 15.663,46 € | — | — |
| azacitidin | Active | 49.125,77 € | — | — |
| paklitaksel | Active | 59.622,05 € | — | — |
| trastuzumab emtanzin | Active | 59.690,80 € | — | — |
| trastuzumab emtanzin | Active | 48.164,80 € | — | — |
| oktreotid | Active | 44.046,44 € | — | — |
| trastuzumab derukstekan | Active | 265.148,71 € | — | — |
| avelumab | Active | 32.740 € | — | — |
| bevacizumab - biološki lijek | Active | 34.914,46 € | — | — |
| bevacizumab - biološki lijek | Active | 173.830,06 € | — | — |
| rituksimab - biološki lijek | Active | 55.495,50 € | — | — |
| trastuzumab - biološki lijek | Active | 104.219,10 € | — | — |
| durvalumab | Active | 272.647,95 € | — | — |
| pembrolizumab - biološki lijek | Active | 2.339.278,91 € | — | — |
| oktreotid | Active | 5.753,30 € | — | — |
| somatropin - biološki lijek | Active | 52.655,30 € | — | — |
| somatropin - biološki lijek | Active | 64.634,70 € | — | — |
| enoksaparin | Active | 2.478,96 € | — | — |
| enoksaparin | Active | 34.919,12 € | — | — |
| enoksaparin | Active | 46.878,70 € | — | — |
| enoksaparin | Active | 27.147,96 € | — | — |
| emicizumab | Active | 103.443,30 € | — | — |
| emicizumab | Active | 108.158,96 € | — | — |
| emicizumab | Active | 118.428,12 € | — | — |
| epoetin alfa - biološki lijek | Active | 25.708,41 € | — | — |
| evolokumab | Active | 14.649,18 € | — | — |
| folitropin alfa - biološki lijek | Active | 5.507,04 € | — | — |
| folitropin alfa - biološki sličan lijek | Active | 3.326,13 € | — | — |
| folitropin alfa, lutropin alfa | Active | 6.228,37 € | — | — |
| somatropin - biološki lijek | Active | 3.507,27 € | — | — |
| somatropin - biološki lijek | Active | 6.303,42 € | — | — |
| somatropin - biološki lijek | Active | 51.820,23 € | — | — |
| atezolizumab | Active | 382.707,60 € | — | — |
| pertuzumab, trastuzumab | Active | 626.298,34 € | — | — |
| pertuzumab, trastuzumab | Active | 53.076,60 € | — | — |
| fulvestrant | Active | 41.971 € | — | — |
| ranibizumab | Active | 2.729,04 € | — | — |
| aflibercept | Active | 117.041,76 € | — | — |
| faricimab | Active | 69.058,86 € | — | — |
| idarucizumab | Active | 2.449,23 € | — | — |
| jopromid | Active | 18.322,08 € | — | — |
| jopromid | Active | 126.885,16 € | — | — |
| gadobutrol | Active | 76.749,20 € | — | — |
| gadoksetinska kiselina | Active | 1.142,40 € | — | — |
| pantoprazol | Active | 33.502,83 € | — | — |
| urzodeoksiholna kiselina | Active | 15.495,90 € | — | — |
| insulin aspart | Active | 223.784,15 € | — | — |
| insulin aspart | Active | 2.119 € | — | — |
| insulin aspart sa protamin insulinom (30%+70%) | Active | 6.626,10 € | — | — |
| insulin glargine | Active | 157.977,50 € | — | — |
| insulin detemir | Active | 110.002,07 € | — | — |
| benralizumab | Active | 54.789,28 € | — | — |
| metformin, sitagliptin | Active | 8.620,56 € | — | — |
| omalizumab | Active | 11.114,69 € | — | — |
| paliperidon | Active | 39.881,20 € | — | — |
| fulvestrant | Active | 5.684,75 € | — | — |
| interferon beta 1a | Active | 37.088,40 € | — | — |
| interferon beta 1b | Active | 56.856,59 € | — | — |
| ofatumumab | Active | 60.726,15 € | — | — |
| infliksimab - biološki lijek | Active | 159.907,04 € | — | — |
| adalimumab - biološki lijek | Active | 365.125,20 € | — | — |
| ustekinumab | Active | 56.320,42 € | — | — |
| ustekinumab | Active | 91.941,74 € | — | — |
| guselkumab | Active | 199.907,37 € | — | — |
| natalizumab | Active | 55.908,96 € | — | — |
| anifrolumab | Active | 26.886,33 € | — | — |
| zoledronska kiselina | Active | 9.368,70 € | — | — |
| risperidon | Active | 24.354,77 € | — | — |
| risperidon | Active | 8.636 € | — | — |
| paliperidon | Active | 45.114,30 € | — | — |
| paliperidon | Active | 14.351,92 € | — | — |